Key takeaways
Jardiance (empagliflozin) and Invokamet (canagliflozin/metformin) are both medications used to manage Type 2 diabetes, but they have some key differences. Jardiance is a single medication that belongs to a sodium-glucose co-transporter 2 (SGLT2) inhibitor class and is taken once daily. It helps lower blood sugar by causing your body to excrete excess sugar through urine and can also reduce the risk of heart and kidney complications. Invokamet, on the other hand, is a combination of two medications: canagliflozin (an SGLT2 inhibitor) and metformin (a biguanide). It is available in both immediate-release tablets taken twice daily and extended-release tablets taken once daily. While both medications can cause urinary tract infections and genital infections, Invokamet also has a risk of lowering vitamin B12 levels and causing bone fractures. Additionally, Jardiance is currently only available as a brand-name medication, with generics expected after 2025, whereas Invokamet is also brand-only. Both medications require a prescription and should be taken with a healthy diet and exercise.
